203 results on '"Stock, R.G."'
Search Results
2. Clinical and Treatment Characteristics of Secondary Rectal and Anal Malignancies following Low Dose Rate Brachytherapy for Prostate Cancer
3. Is The Phoenix Criterion Of Biochemical Failure (BF) In Men Treated With Low-Dose Rate Prostate Brachytherapy Appropriate?
4. Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost: Comparison of outcomes in a multi-institutional analysis of patients with high-risk prostate cancer
5. URINARY MORBIDITY AND INCONTINENCE FOLLOWING TRANSURETHRAL RESECTION OF THE PROSTATE AFTER BRACHYTHERAPY
6. Clinical Outcomes among Patients with Radiorecurrent Gleason Grade Group 5 Prostate Cancer: Impact of Initial Treatment Strategy
7. Durable Disease Control with Local Treatment for Oligoprogression of Metastatic Solid Tumors Treated with Immune Checkpoint Blockade
8. A Biochemical Definition of Cure Following Brachytherapy for Prostate Cancer: A Multi-Institution International Study
9. Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy with Brachytherapy Boost: Comparison of Outcomes in A Multi-Institutional Analysis of 4,086 Patients with High-Risk Prostate Cancer
10. Prostate-Specific Antigen Kinetics Following Various Radiotherapy Modalities: A Multi-Institutional Analysis
11. Complications Following Permanent Prostate Brachytherapy
12. Application of 18-F Fluciclovine PET/CT in Guiding Salvage Radiation Therapy for Recurrent Prostate Cancer
13. Intermediate-Term versus Longer-Term Androgen-Deprivation Therapy for High-Risk Prostate Cancer Treated with High Dose Radiation: 12-Year Outcomes Data
14. Characterization of the Immune Exhaustion Phenotype in Murine Bladder Cancer Following Radiation
15. 2 Year Quality of Life Follow up Following Palladium-103 Line Source for Prostate Brachytherapy Implants
16. Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results from a Multi-institutional Consortium Study
17. Low-Dose-Rate Brachytherapy for Prostate Cancer: Outcomes Beyond 10-years of Follow-Up
18. Whole Pelvis Radiation Therapy Does Not Significantly Improve Prostate-Cancer Specific Survival in Patients With Gleason Score 9-10 Prostate Adenocarcinoma: An Analysis of 942 Patients Treated in the Modern Era
19. Extremely Dose Escalated Radiation Therapy Improves Cancer-Specific Survival Compared With Radical Prostatectomy or Conventionally Dose-Escalated Radiation Therapy in Gleason Score 9-10 Prostate Adenocarcinoma: A Multi-institutional Analysis of 1403 Patie
20. Prostate-Specific Antigen Doubling Time Posttreatment Is the Most Significant Predictor of Survival Following the Brachytherapy Management of Localized Prostate Cancer
21. A Novel Method to Build Intraoperative Flexibility Into Prefabricated or Fixed-Length Low-Dose-Rate Prostate Brachytherapy
22. Outcomes for Patients With Intermediate-, High-, and Very-High-Risk Prostate Cancer Treated With a Combination of External Beam Radiation Therapy and Brachytherapy
23. First Report of a New 103PD Line Source for Prostate Brachytherapy
24. Predicting Long-term Disease State Outcomes in Patients With Prostate Cancer Treated With Definitive Radiation
25. Seminal Vesicle Implantation Does Not Significantly Affect Prostate Cancer Treatment-Related Outcomes
26. Genome-Wide Association Study Identifies a Region on Chromosome 11q14.3 Associated With Late Rectal Bleeding Following Radiation Therapy for Prostate Cancer
27. Predictive Factors and Management of Rectal Bleeding Side Effects Following Prostate Cancer Brachytherapy
28. Genome-wide Association Study to Identify Genetic Variants Associated With the Development of Erectile Dysfunction Following Radiation Therapy for Prostate Cancer
29. The Potential Impact of Medications on Biochemical Control Following Definitive Management of Prostate Cancer
30. The Relative Effects of Biologically Effective Dose (BED) Versus Adjuvant Androgen Suppression (AS) on Biochemical Control and Post-treatment Biopsy Results Following the Brachytherapy Management of Prostate Cancer
31. Adjusted Intermediate and High-Risk Stratification for Prostate Cancer Is More Prognostic Than Current NCCN Risk Grouping
32. Long-term Treatment Outcomes and Morbidity Following the Brachytherapy Management of Localized Prostate Cancer
33. Association of Genetic Factors With PSA Response in Prostate Cancer Patients Receiving Definitive Radiation Therapy
34. PO-149 DEVELOPMENT OF A PRACTICAL PROSTATE BRACHYTHERAPY TRAINING PHANTOM
35. Total BED as a Predictor of Rectal Morbidity in Prostate Cancer Treated with Combined EBRT + Brachytherapy versus Brachytherapy Alone
36. Comparison of Long-term Urinary and Sexual Morbidity in Patients with Prostate Cancer Treated with Different Brachytherapy Regimens
37. Early PSA Failure Time Following Brachytherapy Predicts for Decreased Prostate-Specific and Overall Survival
38. Pretreatment PSA Cutoff and Treatment Escalation for Low Risk Prostate Adenocarcinoma Treated with Brachytherapy Alone
39. Long-term Potency Preservation following Brachytherapy for Prostate Cancer
40. IMRT Causes Fewer Side Effects than 3DCRT when Used in Combination with Brachytherapy for Prostate Cancer
41. Urinary and Sexual Morbidity in Prostate Cancer Patients Treated with Brachytherapy Alone vs. Brachytherapy Plus External Beam Radiation Therapy
42. PSA Nadir of <0.5 ng/mL following Brachytherapy for Early Stage Prostate Adenocarcinoma Predicts for Freedom From PSA Failure and Distant Metastasis
43. Predictors of Metastatic Disease after Prostate Brachytherapy
44. Impact of Hormonal Therapy in the Management of Intermediate Risk Prostate Cancer Treated with Permanent Prostate Brachytherapy and External Beam Irradiation
45. Impact of Race on Biochemical Control following Brachytherapy for Prostate Cancer
46. Assessing Grade 2-4 Proctitis in Patients Undergoing Combined Modality Therapy for Prostate Cancer: An Innovative Approach to Determine BED Dose Volume Toxicity
47. Long-term Outcomes and Toxicity of Salvage Brachytherapy for Local Failure after Initial Radiotherapy for Prostate Cancer
48. The Effect of Adjuvant Hormone Therapy on Biochemical Control, Sexual Function, and Urinary Symptoms in Low Risk Prostate Cancer Patients Treated with Brachytherapy
49. Comparison of Dose and Volume Parameters for Prostate Brachytherapy in Prediction of Biochemical Failure
50. Long-term Complications in Patient with Prostate Cancer Treated with Combination Brachytherapy, External Beam Radiation Therapy, and Hormone Ablation Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.